Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel W Nebert

Showing results (31-40 of 168) with videos related to

Pageof 17
Sort By:
Human Genomics|April 6, 2006
Update of the NAD(P)H:quinone oxidoreductase (NQO) gene familyVasilis Vasiliou, David Ross, Daniel W Nebert
Human Genomics|January 24, 2009
Analysis and update of the human solute carrier (SLC) gene superfamilyLei He, Konstandinos Vasiliou, Daniel W Nebert
Human Genomics|December 3, 2009
Evolutionary divergence and functions of the ADAM and ADAMTS gene familiesChad N Brocker, Vasilis Vasiliou, Daniel W Nebert
Drug Metabolism Reviews|May 9, 2008
From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directionsDaniel W Nebert, Ge Zhang, Elliot S Vesell
Annual Review of Pharmacology and Toxicology|January 9, 2013
Genetic risk prediction: individualized variability in susceptibility to toxicantsDaniel W Nebert, Ge Zhang, Elliot S Vesell
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|January 9, 2013
Human cytochromes P450 in health and diseaseDaniel W Nebert, Kjell Wikvall, Walter L Miller
Human Genomics|April 7, 2010
Update of human and mouse matrix metalloproteinase familiesBrian C Jackson, Daniel W Nebert, Vasilis Vasiliou
Pharmacogenetics and Genomics|May 19, 2006
Statistical power of association using the extreme discordant phenotype designGe Zhang, Daniel W Nebert, Ranajit Chakraborty, et al.
JAMA|August 15, 2006
Coffee, myocardial infarction, and CYP nomenclatureMagnus Ingelman-Sundberg, Sarah C Sim, Daniel W Nebert
Human Genomics|November 24, 2023
Emerging trends in pharmacogenomics: from common variant associations toward comprehensive genomic profilingMagnus Ingelman-Sundberg, Daniel W Nebert, Volker M Lauschke
Pageof 17

Showing results (31-40 of 168) with videos related to

Sort By:
Pageof 17
Human Genomics|April 6, 2006
Update of the NAD(P)H:quinone oxidoreductase (NQO) gene familyVasilis Vasiliou, David Ross, Daniel W Nebert
Human Genomics|January 24, 2009
Analysis and update of the human solute carrier (SLC) gene superfamilyLei He, Konstandinos Vasiliou, Daniel W Nebert
Human Genomics|December 3, 2009
Evolutionary divergence and functions of the ADAM and ADAMTS gene familiesChad N Brocker, Vasilis Vasiliou, Daniel W Nebert
Drug Metabolism Reviews|May 9, 2008
From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directionsDaniel W Nebert, Ge Zhang, Elliot S Vesell
Annual Review of Pharmacology and Toxicology|January 9, 2013
Genetic risk prediction: individualized variability in susceptibility to toxicantsDaniel W Nebert, Ge Zhang, Elliot S Vesell
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|January 9, 2013
Human cytochromes P450 in health and diseaseDaniel W Nebert, Kjell Wikvall, Walter L Miller
Human Genomics|April 7, 2010
Update of human and mouse matrix metalloproteinase familiesBrian C Jackson, Daniel W Nebert, Vasilis Vasiliou
Pharmacogenetics and Genomics|May 19, 2006
Statistical power of association using the extreme discordant phenotype designGe Zhang, Daniel W Nebert, Ranajit Chakraborty, et al.
JAMA|August 15, 2006
Coffee, myocardial infarction, and CYP nomenclatureMagnus Ingelman-Sundberg, Sarah C Sim, Daniel W Nebert
Human Genomics|November 24, 2023
Emerging trends in pharmacogenomics: from common variant associations toward comprehensive genomic profilingMagnus Ingelman-Sundberg, Daniel W Nebert, Volker M Lauschke
Pageof 17